Explore more publications!

Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

Press releases published on October 2, 2025

Nacuity Pharmaceuticals Granted U.S. FDA Breakthrough Therapy Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa
Climb Channel Solutions named as one of “America’s Greatest Companies 2025” by Newsweek
Acronis and CyberCert Partner to Empower MSPs in Australia with SMB1001 Certification Pathways
Roper Technologies schedules third quarter 2025 financial results conference call
Why the Billion Dollar Rare Earth Elements (REE) Market is Projected for Substantial Expansion in Coming Years
Champion Safe Company Expands Dealer Network with Guardian Lock & Security in Bismarck, North Dakota
Snail Games Strengthens Publishing Portfolio Visibility at TwitchCon Through Strategic Partnership with Noiz
CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025
Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference
Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
Nuvini Group Announces Reverse Stock Split
Rocket Doctor Partners with Remmie to Bring FDA Approved and Health Canada Cleared Smart Otoscope to Patients
BioCardia Regains Compliance with Nasdaq Listing Requirements
ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer
Starton Therapeutics Announces Promotion of Rod Hartwig to Vice President of Research and Development and Manufacturing
AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meeting
Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2025 AANEM Annual Meeting
Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome
Curonix Publishes Results for the First and Only IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA 510(k) Expanded Indication for Treating Chronic Craniofacial Pain

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions